EMA expects Johnson & Johnson to file for vaccine approval within days
EMA expects Johnson & Johnson to file for vaccine approval within days New BioNTech production site will have capacity to produce 750m doses annually Fri, Feb 12, 2021, 17:04 Updated: Fri, Feb 12, 2021, 21:26 The first stage of BioNTech’s vaccine process, producing the active ingredient known as mRNA, has begun at a new plant in Marburg. Photograph: AFP via Getty The European Medicines Agency (EMA) expects Johnson & Johnson to file for approval of its Covid-19vaccine in the EU wit...
Source: irishtimes.com